Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

WK Kellogg beats Q4 profit estimates but sales fall short

(Sharecast News) - American cereal manufacturer WK Kellogg delivered a mixed set of quarterly results on Tuesday as sales fell short of forecasts but profits smashed estimates. The Michigan-based company said adjusted EBITDA totalled $57m for the three months to 28 December, up 7.5% on last year, with adjusted earnings per share of 42 cents coming in comfortably above the 25 cents expected by the market.

That meant that full-year adjusted EBITDA improved by 3% to $275m, topping the guidance range provided by the manufacturer.

Sales, however, were down 1.8% year-on-year at $640m, missing the $645m estimate, which the company blamed on the "ongoing challenging business environment", as well as a weakening CAD-USD exchange rate.

Full-year reported sales were down 2% on 2023 at $2.71bn.

Looking ahead, WK Kellogg pointed to a 1% decline in organic net sales in 2025, but 4-6% growth in full-year adjusted EBITDA - ahead of current analysts' predictions.

However, the company noted that the 2025 guidance doesn't include any potential impact from trade tariffs on Mexican and Canadian imports into the US, as recently announced by the Trump administration.

Shares were 1.2% higher at $16.44 by 1029 in New York.

Share this article

Related Sharecast Articles

Clean Power Hydrogen signs MoU with Irish firm Constant Energy
(Sharecast News) - Clean Power Hydrogen (CPH2) announced the signing of a memorandum of understanding with Irish energy developer Constant Energy on Monday, marking a key step in the commercial rollout of its proprietary Membrane-Free Electrolyser (MFE) technology.
SkinBioTherapeutics inks Superdrug deal, raises £4.1m
(Sharecast News) - SkinBioTherapeutics announced on Monday that it has signed an exclusive UK commercial agreement with Superdrug for its 'AxisBiotix' range of food supplements targeting inflammatory skin conditions, while also raising £4.1m through a placing and subscription to support the rollout and related operational needs.
Safestay secures £1.4m payout for Covid-19 interruptions
(Sharecast News) - Safestay announced on Monday that it has secured a £1.4m payout from a business interruption insurance claim related to the impact of the Covid-19 pandemic.
Power Metal opts out of proposed Saudi Arabia deal
(Sharecast News) - Power Metal Resources confirmed on Monday that it would not proceed with a previously-proposed agreement with Saudi Arabia's Al Masane Al Kobra Mining Company (AMAK) to acquire a stake in the Qatan exploration licence.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.